REHOVOT, Israel & RICHMOND, Va.--(BUSINESS WIRE)--On the heels of its presentation at the annual meeting of the American College of Rheumatology in San Francisco last month – its sixth presentation at international medical conferences in as many months – the developer of a new rule-out test for lupus is broadening the test’s availability throughout the United States.
ImmunArray, developer of SLE-key Rule-Out Test® – a simple, cost-efficient blood test that can rule out the presence of Systemic Lupus Erythematosus (SLE or lupus) with unprecedented levels of accuracy – is now available through leading rheumatologists in all regions of the country.
